TransMedics Group

TMDXleader

TransMedics invented warm machine perfusion for organs, transforming the transplant industry by keeping donor hearts, lungs, and livers viable for far longer — increasing the number of viable transplants.

⇄ Compare

产品与营收

产品营收占比

营收构成 ($403M)

静态数据（加载实时财务…）

OCS Product Sales (68%)

NOCP Services (32%)

业务板块构成与主要客户

产品详情

Organ Care System (OCS) — Heart55%

Portable device that keeps donor hearts warm and beating outside the body, extending viability and enabling distant transplants.

OCS Lung & Liver35%

Lung and liver perfusion systems providing the same warm ischemia-time extension for thoracic and abdominal organs.

National OCS Program (NOCP)10%

Turnkey organ retrieval, transport, and transplant logistics service operated by TransMedics staff.

供应链关系

合作伙伴

Johnson & Johnson

Surgical tools for OCS procedures

影响: moderate

宏观与市场背景

헬스케어行业新闻

메디케어 수가 압박 vs AI 진단 효율화 — 선별적 접근 필요

미국 헬스케어 지출 (2026E)

$4.8T

AI 진단 정확도 개선

+23% vs 기존

UNH 의료손해율

87.3%

약가 협상 대상 의약품

20종 (IRA)

近期催化剂

◆CMS 메디케어 최종 수가 발표 (2026.Q2)◆UNH/HUM/CVS Q1 실적 (2026.04)◆IRA 약가 협상 2차 품목 공개

AI 分析

点击「获取 AI 分析」以获得 TransMedics Group 的 AI 供应链分析。

企业信息

总部

Andover, Massachusetts, USA

成立时间

1998

员工人数

1,100

官网

transmedics.com

行业概况 — 헬스케어

行业新闻